Literature DB >> 17720103

Multicenter study of the validity and reliability of subjective global assessment in the hemodialysis population.

Alison Steiber1, Janeen B Leon, Donna Secker, Maureen McCarthy, Linda McCann, Monica Serra, Ashwini R Sehgal, Kamyar Kalantar-Zadeh.   

Abstract

OBJECTIVE: Subjective Global Assessment (SGA) is a nutrition assessment tool recommended by the 2000 NKF K/DOQI Nutrition Guidelines. However, the validity and reliability of this tool have not been established in hemodialysis (HD) patients. The purpose of this observational study was to determine the reliability and validity of SGA in the HD population. Renal dietitians (RD) were recruited to perform SGA (7-point scale version) and collect data on demographics, clinical status, biochemistries, dietary intake, and quality of life (Medical Outcomes Short Form-36) on 3 HD patients at baseline and 6 months later.
DESIGN: The 54 participating RDs were trained to perform SGA and collect data via a website created for this study. Interrater reliability for SGA was tested in a subset of 76 patients, via an SGA performed by a second RD at baseline, while intrarater reliability was assessed by the original RD repeating the SGA at 1 month. Data collection occurred at HD facilities in the United States (109 patients), Canada (35 patients), and New Zealand (9 patients).
RESULTS: Of the 153 patients, 46% were female, 64% were Caucasian, 6% were Hispanic, 21% were African American, and 6% were Asian. The primary etiologies were hypertension (33%), type 2 diabetes mellitus (DM) (27%), type 1 DM (10%), and glomerular nephritis (10%); 59% had cardiovascular disease. The mean age, body mass index (BMI), serum albumin, and duration on HD were 64 +/- 14 years (mean +/- SD), 28 +/- 7 kg/m(2), 3.7 +/- 0.4 mg/dL, and 41 +/- 34 months, respectively. SGA scores were well nourished (7)-30%; mildly malnourished (MN 6)-41%; moderately MN 5-21%, 4-7%, and 3-2%; and severely MN (2 and 1)-0%. SGA training via the Internet achieved fair interrater reliability (weighted Kappa = 0.5, Spearman's Rho = 0.7) and substantial intrarater reliability (weighted Kappa = 0.7, Spearman's Rho = 0.8) (P < .001). Validity was demonstrated through statistically significant differences in mean BMI and serum albumin across the 5 categories of SGA (7-28 +/- 7, 6-29 +/- 7, 5-28 +/- 8, 4-21 +/- 4, 3-24 +/- 2, P < .05; and 7-3.8 +/- 0.3, 6-3.8 +/- 0.4, 5-37 +/- 0.05, 4-3.4 +/- 0.07, 3-2.9 +/- 1.2, P < .001, respectively). Nutritional status varied by age (P < .05), but not ethnicity or nationality.
CONCLUSION: We conclude that the 7-point scale SGA is a reliable and valid tool for nutritional assessment in adults on HD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17720103     DOI: 10.1053/j.jrn.2007.05.004

Source DB:  PubMed          Journal:  J Ren Nutr        ISSN: 1051-2276            Impact factor:   3.655


  23 in total

1.  Subjective Global Assessment-Dialysis Malnutrition Score and cardiovascular risk in hemodialysis patients: an observational cohort study.

Authors:  Leonardo Spatola; Silvia Finazzi; Albania Calvetta; Francesco Reggiani; Emanuela Morenghi; Silvia Santostasi; Claudio Angelini; Salvatore Badalamenti; Giacomo Mugnai
Journal:  J Nephrol       Date:  2018-06-23       Impact factor: 3.902

2.  Nutritional problems, overhydration and the association with quality of life in elderly dialysis patients.

Authors:  Inger Karin Lægreid; Asta Bye; Knut Aasarød; Marit Jordhøy
Journal:  Int Urol Nephrol       Date:  2012-09-22       Impact factor: 2.370

3.  NF-κB expression and its association with nutritional status in hemodialysis patients.

Authors:  Najla E Farage; Milena B Stockler-Pinto; Viviane O Leal; Ludmila Lmf Cardozo; José Carlos Carraro-Eduardo; Denis Fouque; Denise Mafra
Journal:  Int Urol Nephrol       Date:  2016-09-27       Impact factor: 2.370

4.  Comparison analysis of nutritional scores for serial monitoring of nutritional status in hemodialysis patients.

Authors:  Ilia Beberashvili; Ada Azar; Inna Sinuani; Hadas Kadoshi; Gregory Shapiro; Leonid Feldman; Zhan Averbukh; Joshua Weissgarten
Journal:  Clin J Am Soc Nephrol       Date:  2013-02-14       Impact factor: 8.237

5.  Comparison of Subjective Global Assessment and Protein Energy Wasting Score to Nutrition Evaluations Conducted by Registered Dietitian Nutritionists in Identifying Protein Energy Wasting Risk in Maintenance Hemodialysis Patients.

Authors:  Simon Siu-Man Sum; Andrea F Marcus; Debra Blair; Laura A Olejnik; Joyce Cao; J Scott Parrott; Emily N Peters; Rosa K Hand; Laura D Byham-Gray
Journal:  J Ren Nutr       Date:  2017-06-07       Impact factor: 3.655

6.  Vitamins K and D status in stages 3-5 chronic kidney disease.

Authors:  Rachel M Holden; A Ross Morton; Jocelyn S Garland; Andrey Pavlov; Andrew G Day; Sarah L Booth
Journal:  Clin J Am Soc Nephrol       Date:  2010-02-18       Impact factor: 8.237

7.  Broadening Options for Long-term Dialysis in the Elderly (BOLDE): differences in quality of life on peritoneal dialysis compared to haemodialysis for older patients.

Authors:  Edwina A Brown; Lina Johansson; Ken Farrington; Hugh Gallagher; Tom Sensky; Fabiana Gordon; Maria Da Silva-Gane; Nigel Beckett; Mary Hickson
Journal:  Nephrol Dial Transplant       Date:  2010-04-16       Impact factor: 5.992

8.  Comparison of Bioelectrical Impedance Vector Analysis (BIVA) to 7-point Subjective Global Assessment for the diagnosis of malnutrition.

Authors:  Clara S A Sugizaki; Nayara P Queiroz; Débora M Silva; Ana T V S Freitas; Nara A Costa; Maria R G Peixoto
Journal:  J Bras Nefrol       Date:  2022 Apr-Jun

9.  Nutrition changes in conservatively treated patients with encapsulating peritoneal sclerosis.

Authors:  Nevine El-Sherbini; Neill Duncan; Mary Hickson; Lina Johansson; Edwina A Brown
Journal:  Perit Dial Int       Date:  2013-07-01       Impact factor: 1.756

10.  Impact of malnutrition on health-related quality of life in persons receiving dialysis: a prospective study.

Authors:  Daniela Viramontes-Hörner; Zoe Pittman; Nicholas M Selby; Maarten W Taal
Journal:  Br J Nutr       Date:  2021-07-05       Impact factor: 4.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.